Yunsheng Yang | Inflammatory Bowel Disease | Best Researcher Award

Prof. Dr. Yunsheng Yang | Inflammatory Bowel Disease | Best Researcher Award

The First Medical Center, Chinese PLA General Hospital | China

AUTHOR PROFILE

ORCID ID

🌟YUNSHENG YANG, M.D. – A LEADER IN GASTROENTEROLOGY 🏥

🎓EARLY ACADEMIC PURSUITS 

Dr. Yunsheng Yang earned his M.D. from the First Military Medical University in 1995, laying the foundation for his illustrious medical career. He pursued postdoctoral training at the Fourth Military Medical University in China, further honing his expertise in gastroenterology. His academic journey extended internationally with visiting scholar positions at the University of Sydney’s Westmead Hospital in 2008 and Mayo Clinic Rochester in 2014, where he gained invaluable global exposure to advanced medical practices.

👩‍🏢PROFESSIONAL ENDEAVORS 

Currently, Dr. Yang serves as the Academic Director of the Department of Gastroenterology and Hepatology at the First Medical Center, Chinese PLA General Hospital (PLAGH, 301 Hospital) in Beijing, China. His leadership extends beyond national borders, with visiting or adjunct professorships at Shenzhen University, Universitas Amoiensis, and the University of Michigan, USA.

His involvement in prestigious medical societies includes being the immediate past president of the Chinese Society of Gastroenterology and the Director of the APSDE Training Center in PLAGH since 2006. Dr. Yang actively engages with the World Gastroenterology Organization (WGO), serving as a scientific committee member and having previously contributed to the WGO Endoscopy Group and Nomination Committee.

🔬CONTRIBUTIONS AND RESEARCH FOCUS 

Dr. Yang’s clinical expertise primarily revolves around gastrointestinal (GI) disorders and therapeutic Endoscopic Retrograde Cholangiopancreatography (ERCP). His research is focused on robot-assisted endoscopy and GI microbiota, where he has pioneered multiple innovative procedures in China, including:

  • Endoscopic suturing for GERD (2001)
  • Double balloon enteroscopy (2003)
  • Peroral video cholangioscopy and laser lithotripsy (2004)
  • Confocal endomicroscopy (2006)
  • MUSE for GERD (2017)
  • Fecal Microbiota Transplantation (FMT) clinical trials for IBD, autism, and Tourette syndrome (since 2014)

Notably, he led the development of the YunSRobot, a robot-assisted GI endoscopy system, successfully performing gastroscopy on human volunteers in 2017 and completing remote gastroscopy in 2021. These groundbreaking achievements have been published and indexed in PubMed.

📚IMPACT AND INFLUENCE 

Dr. Yang’s influence in the field of gastroenterology is reflected in his extensive publication record. He has authored over 200 articles in Chinese journals and more than 150 papers in international SCI-indexed journals, including prestigious titles such as Gastroenterology, Hepatology, The American Journal of Gastroenterology (AJG), Gastrointestinal Endoscopy (GIE), Alimentary Pharmacology & Therapeutics (AP&T), and Gut.

As an editorial board member for Gut and AP&T, and associate editor for MMR and JDD, he continues to shape the direction of gastroenterology research and clinical practice worldwide.

🌟ACADEMIC CITES AND RECOGNITION 

Dr. Yang’s research contributions have been extensively cited by peers in the medical and scientific communities. His innovations in endoscopic procedures and gastrointestinal microbiota research have influenced treatment protocols and technological advancements in digestive health worldwide. His pioneering work on FMT for neurological conditions and robotic-assisted endoscopy is setting new standards in precision medicine.

💪LEGACY AND FUTURE CONTRIBUTIONS 

Dr. Yang’s enduring legacy lies in his transformative impact on gastroenterology, blending cutting-edge technology with clinical expertise. His leadership in developing robotic-assisted endoscopy has the potential to revolutionize non-invasive diagnostics and treatment, paving the way for AI-integrated endoscopic procedures.

Looking ahead, Dr. Yang continues to push the boundaries of GI research, particularly in the integration of robotics, microbiota-based therapies, and novel endoscopic interventions. His mentorship of young gastroenterologists ensures a lasting impact on the field, fostering the next generation of leaders in digestive health research and clinical innovation.

🌍CONCLUSION 

Dr. Yunsheng Yang stands as a trailblazer in the field of gastroenterology, with his extensive contributions in clinical practice, research, and technological innovation. His groundbreaking advancements in robot-assisted endoscopy and GI microbiota research have set new benchmarks in the medical field. His dedication to patient care, scientific discovery, and mentorship ensures his influence will resonate for years to come, shaping the future of digestive health worldwide.

 

📊🔬NOTABLE PUBLICATION:
  1. Title: Fecal microbiota transplantation significantly improved respiratory failure of amyotrophic lateral sclerosis.
    Authors: Yan J, Chen H, Zhang Y, Peng L, Wang Z, Lan X, Yu S, Yang Y.
    Year: 2024

 

  1. Title: Dynamic changes in the gut microbiota after bismuth quadruple therapy and high-dose dual therapy for Helicobacter pylori eradication.
    Authors: Chen J, Zhang Y, Min H, Zhi J, Ma S, Dong H, Yan J, Chi X, Zhang X, Yang Y.
    Year: 2024

 

  1. Title: Colorectal cancer and gut microbiota studies in China.
    Authors: Wang Z, Dan W, Zhang N, Fang J, Yang Y.
    Year: 2023

 

  1. Title: The fecal microbiota from children with autism impact gut metabolism and learning and memory abilities of honeybees.
    Authors: Li Y, Zhang Y, Luo X, Meng Y, Zhong Z, Zheng H, Yang Y.
    Year: 2023

 

  1. Title: Deep insights into the gut microbial community of extreme longevity in South Chinese centenarians by ultra-deep metagenomics and large-scale culturomics.
    Authors: Li C, Luan Z, Zhao Y, Chen J, Yang Y, Wang C, Jing Y, Qi S, Li Z, Guo H, et al.
    Year: 2022

Dr. Jordan Leal | Stem Cell Therapy | Best Researcher Award

Dr. Jordan Leal | Stem Cell Therapy | Best Researcher Award

University of Kansas Cancer Center | United States

Author Profile

ORCID ID

🏥Professional Summary

  • Jordan Leal is a board-certified Nurse Practitioner with extensive experience in hematologic malignancies, cellular therapeutics, and blood and marrow transplantation at the University of Kansas Health System (TUKHS). Since joining TUKHS in 2009 and advancing to the role of Nurse Practitioner in 2014, Jordan has become proficient in critical procedures such as bone marrow biopsies, lumbar punctures, and the administration of intrathecal chemotherapy. In December 2023, Jordan graduated with a Doctor of Nursing Practice (DNP), further specializing in quality improvement through projects focused on early detection of steroid-induced hyperglycemia. Jordan is dedicated to advancing transplant medicine, regularly attending industry conferences, including ASTCT Tandem Meetings and regional symposia on hematologic malignancies.

👩‍⚕️Employment History

  • BMT APP Coordinator | Blood and Marrow Transplant Program, University of Kansas Cancer Center
  • 2022 – Present
  • Nurse Practitioner | Blood and Marrow Transplant Program, University of Kansas Cancer Center
  • 2014 – Present
  • Registered Nurse | Medical/Transplant Intensive Care Unit, University of Kansas Health System
  • 2009 – 2014

🎓Education

  • Doctor of Nursing Practice (DNP) | University of Kansas School of Nursing
  • Graduated: December 2023
  • Project: “Implementing a Standardized Workflow for Early Detection of Steroid-Induced Hyperglycemia”
  • Master of Science in Nursing (MSN) | University of Kansas School of Nursing
  • Graduated: May 2014
  • Specialization: Adult-Gerontology
  • Bachelor of Science in Nursing (BSN) | University of Kansas School of Nursing
  • Graduated: May 2009

🏆Honors and Awards

  • APP Best Abstracts, 3rd Place (2024)
  • APP of the Year Nominee (2023)
  • School of Nursing Spring 2023 Scholarship Award
  • KUMC Auxiliary Grant Recipient (2022)
  • Dean’s Award for Outstanding Service (2009)

🎤Presentations and Lectures

  • Podium Presentation: “Implementing a Standardized Workflow for Early Detection of Steroid-Induced Hyperglycemia in Allogeneic Stem Cell Transplant Recipients,” ASTCT Tandem Meetings (2024)
  • Virtual Presentation: “Advanced Cell Therapy: BiTE/TriTE, Allogeneic CAR-T, Off-the-Shelf Products,” ASTCT Clinical Education Conference (2023)
  • Poster Presentation: “Managing Steroid-Induced Hyperglycemia in Allogeneic Stem Cell Transplant with Onco-Endocrinology Team,” APP Symposium, TUKHS (2022)

đź“„Certifications

  • Adult-Gerontology Nurse Practitioner | American Academy of Nurse Practitioners Certification Board (AANP), Expires: Dec 2024
  • Blood and Marrow Transplant Certified Nurse (BMTCN) | Oncology Nursing Certification Corporation, Expires: Dec 2025
  • ONS Chemotherapy/Biotherapy Certification | Oncology Nursing Society, Expires: Aug 2024
  • Basic Life Support | American Heart Association, Expires: Mar 2024

👥Professional Affiliations

  • American Society for Transplantation and Cellular Therapy (ASTCT) | Member since 2023

đź“‹Professional Committees

  • APP Peer Review Committee | The University of Kansas Health System, May 2020 – Present
  • APP Professional Subcommittee | The University of Kansas Health System, February 2023 – Present
  • Continuing Education Conference (CEC) Planning Committee | American Society for Transplantation and Cellular Therapy, Summer 2022 – Present

✨Conclusion:

  • Jordan Leal, DNP, AGNP-C, BMTCN, exemplifies dedication to advancing clinical excellence in hematologic and cellular therapeutics. With over a decade of specialized experience at the University of Kansas Health System, Jordan’s expertise spans critical procedural skills, quality improvement projects, and comprehensive patient care in blood and marrow transplant. Jordan’s academic achievements, industry-recognized presentations, and active involvement in professional committees underscore a commitment to both innovative patient care and professional development. Through continued education, research, and mentorship, Jordan Leal is a driving force in improving outcomes and shaping the future of transplant nursing.

📊🔬NOTABLE PUBLICATION:

  • Title: Implementing a Standardized Workflow for Early Detection of Steroid-Induced Hyperglycemia in Allogeneic Stem Cell Transplant Recipients: A Quality Improvement Project
    • Authors: Jordan Leal, William Wesson, Liza Rodriguez, Jason Gray, Kelly Bosak, Joseph McGuirk, Kristin Grdinovac
      Journal: Transplantation Reports
      Year: 2024